Connection

Sherief Abd-Elsalam to Sofosbuvir

Back to Details
This is a "connection" page, showing publications Sherief Abd-Elsalam has written about Sofosbuvir.
Sherief Abd-Elsalam
Connection Strength
2.204
Sofosbuvir
  1. Outcomes of Treatment and Predictors of Response to Sofosbuvir Plus Simeprevir in Hepatitis C Virus with Genotype-4 Infection. Infect Disord Drug Targets. 2020; 20(3):389-395.
    View in: PubMed
    Score: 0.568
  2. Sofosbuvir, Pegylated Interferon and Ribavirin in the Treatment of an Egyptian Cohort with Hepatitis C Virus Infection in Real-Life Clinical Practice. Infect Disord Drug Targets. 2019; 19(2):179-184.
    View in: PubMed
    Score: 0.530
  3. Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice. Arch Virol. 2018 Jan; 163(1):51-56.
    View in: PubMed
    Score: 0.486
  4. Efficacy of Sofosbuvir Plus Ribavirin with or Without Peginterferon- Alfa in Treatment of a Cohort of Egyptian Patients with Hepatitis C Virus Infection. Infect Disord Drug Targets. 2017; 17(2):95-100.
    View in: PubMed
    Score: 0.462
  5. Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study. Expert Rev Anti Infect Ther. 2022 02; 20(2):291-295.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.